Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes

International Journal of Experimental Pathology

Volumn 93, Issue 1, 2012, Pages 56-69

  Kunjara, Sirilaksana ^a   Greenbaum, A Leslie ^a   Sochor, Milena ^a   Ali, Murad ^a   Flyvbjerg, Allan ^b   Grønbaek, Henning ^b   McLean, Patricia ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adrenal hypertrophy; Angiopeptin; Experimental diabetes (STZ); Insulin; Phosphoribosylpyrophosphate formation and utilization; Sandostatin

Indexed keywords

ANGIOPEPTIN; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INSULIN; OCTREOTIDE; PHOSPHORIBOSYL PYROPHOSPHATE; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; STREPTOZOCIN;

ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ADRENAL GLANDS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; INSULIN; MALE; NICOTINAMIDE MONONUCLEOTIDE; NUCLEOTIDES; OCTREOTIDE; OLIGOPEPTIDES; PENTOSE PHOSPHATE PATHWAY; PHOSPHORIBOSYL PYROPHOSPHATE; RATS; RATS, WISTAR; SOMATOSTATIN; STREPTOZOCIN;

EID: 84856185894     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2011.00801.x     Document Type: Article

References (63)

1. Alderton F., Lauder H., Feniuk W., Fan T.P., Humphrey P.P. (1998) Differential effects of somatostatin and angiopeptin on cell proliferation. Br. J. Pharmacol. 124, 323-330.
2. Barbieri M., Bonafe M., Franceschi C., Paolisso G. (2003) Insulin/IGF-1-signaling pathway: an evolutionary conserved mechanism of longevity from yeast to humans. Am. J. Physiol. Endocrinol. Metab. 285, E1064-E1071.
3. Becker M.A. (2001) Phosphoribosylpyrophosphate synthase and the regulation of phosphoribosylpyrophosphate production in human cells. Prog. Nucleic Acid Res. Mol. Biol. 69, 115-148.
4. Becker M.A., Raivio K.O., Seegmiller J.E. (1979) Synthesis of phosphoribosyl pyrophosphate in mammalian cells. Adv. Enzymol. Relat. Areas Mol. Biol. 49, 281-306.
5. Branster M.J. & Morton R.K. (1956) Comparative rates of synthesis of diphosphopyridine nucleotide by normal and tumour tissue from mouse mammary gland: studies with isolated nuclei. Biochem. J. 65, 413-416.
6. Brownlee M. & Cerami A. (1981) The biochemistry of the complications of diabetes mellitus. Annu. Rev. Biochem. 50, 385-432.
7. Chambers D.A., Martin D.W., Weinstein Y. (1974) The effect of cyclic nucleotides on purine biosynthesis and the induction of PRPP synthetase during lymphocyte activation. Cell 3, 375-380.
8. Corda D. & Di Girolamo M. (2003) Functional aspects of protein mono-ADP-ribosylation. EMBO J. 22, 1953-1958.
9. Criss W.E. & Mckerns K.W. (1968) Activation of cow adrenal glucose 6-phosphate dehydrogenase by adrenocorticotrophin. Biochemistry 7, 2364-2368.
10. De Nicola A.F., Fridman O., Del Castillo E.J., Foglia V.G. (1976) Influence of streptozotocin diabetes on adrenal function in male rats. Horm. Metab. Res. 8, 388-392.
11. De Nicola A.F., Fridman O., Castillo E., Foglia V.G. (1977) Abnormal regulation of adrenal function in rats with streptozotocin diabetes. Horm. Metab. Res. 9, 469-473.
12. Dimitriadis G., Parry-Billings M., Bevan S. et al. (1992) Effect of insulin-like growth factor-1 on rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem. J. 285, 269-274.
13. Drop S.L.S., Brinkman A., Cortleve D.J., Groffen C.A.H., Schuller A.Z., Warthoff E.C. (1991) The evolution of the insulin-like growth factor binding family. In: Modern Concepts of Insulin-like Growth Factor, pp. 311-328 (ed. E.M. Spencer), New York: Elsevier.
14. Ezzat S. & Melmed S. (1992) Endocrine applications of the somatostatin analogue octreotide (Sandostatin). Metabolism 41, 34-38.
15. Fine L.G., Hammerman M.R., Abboud H.E. (1992) Evolving role of growth factors in the renal response to acute and chronic disease. J. Am. Soc. Nephrol. 2, 1163-1170.
16. Flyvbjerg A. (1997) Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in renal complications of diabetes. Kidney. Int. Suppl. 60, S12-S19.
17. Flyvbjerg A. (2004) The role of growth hormone in the pathogenesis of diabetic kidney disease. Pediatr. Endocrinol. Rev. 1(Suppl. 3), 525-529.
18. Flyvbjerg A., Thorlacius-Ussing O., Naeraa R., Ingerslev J., Ørskov H. (1988) Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31, 310-314.
19. Flyvbjerg A., Frystyk J., Thorlacius-Ussing O., Ørskov H. (1989) Somatostatin analogue administration prevents increase in kidney somatomedin C and renal growth in diabetic and uninephrectomised rats. Diabetologia 32, 261-265.
20. Flyvbjerg A., Bornfeldt K.E., Marshall S.M., Arnqvist H.J., Ørskov H. (1990) Kidney IGF-1 mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 33, 334-338.
21. Flyvbjerg A., Bornfeldt K.E., Ørskov H., Arnqvist H.J. (1991) Effects of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats. Diabetologia 34, 715-720.
22. Flyvbjerg A., Kessler U., Dorka B., Funk B., Ørskov H., Kiess W. (1992) Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35, 589-593.
23. Fontana L., Partridge L., Longo V.D. (2010) Extending healthy life span - from yeast to humans. Science 328, 321-326.
24. Garten A., Petzold S., Korner A., Imai S.-I., Kiess W. (2009) Nampt: linking NAD biology, metabolism and cancer. Trends. Endocrinol. Metab. 20, 130-138.
25. Gholson R.K. (1966) The pyridine nucleotide cycle. Nature 212, 933-934.
26. Glock G.E. & McLean P. (1957) Levels of oxidized and reduced diphophosphopyridine nucleotide and triphosphopyridine nucleotide in tumours. Biochem. J. 65, 413-416.
27. Grønbaek H., Nielsen B., Schrijvers B., Vogel I., Rasch R., Flyvbjerg A. (2002) Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice. J. Endocrinol. 172, 637-643.
28. Hammerman M.R. (1989) The growth hormone-insulin-like growth factor axis in kidney. Am. J. Physiol. (Renal Fluid Electrolyte Physiol) 257, F503-F514.
29. Herner S. & Farber M. (1990) The insulin family of peptides in early mammalian development. Curr. Top. Dev. Biol. 24, 137-159.
30. Imai S. (2009a) Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr. Pharm. Des. 15, 20-28.
31. Imai S. (2009b) The NAD World: a new systematic regulatory network for metabolism and aging - Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem. Biophys. 53, 65-74.
32. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800.
33. Jedeikin L.A. & Weinhouse S. (1955) Metabolism of neoplastic tissue. V1. Assay of oxidized and reduced diphosphopyridine nucleotide in normal and neoplastic tissues. J. Biol. Chem. 213, 271-280.
34. Kunjara S., Sochor M., Adeoya A., McLean P., Greenbaum A.L. (1986a) Concentration of phosphoribosyl pyrophosphate in the kidney during development and in experimental diabetic hypertrophy. Biochem. J. 234, 579-585.
35. Kunjara S., Sochor M., Salih N., McLean P., Greenbaum A.L. (1986b) Phosphoribosyl pyrophosphate and phosphoribosyl pyrophosphate synthetase in rat mammary gland. Changes in the lactation cycle and the effects of diabetes, insulin and phenazine methosulphate. Biochem. J. 238, 553-559.
36. Kunjara S., Sochor M., Ahmed S., Greenbaum A.L., McLean P. (1992) Phosphoribosyl pyrophosphate formation in the rat adrenal gland in relation to adrenal growth in experimental diabetes. Diabetes 41, 1429-1435.
37. Landry J., Slama J.T., Sternglanz R. (2000) Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochim. Biophys. Res. Commun. 278, 685-690.
38. Lee H.C. (2001) Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu. Rev. Pharmacol. Toxicol. 41, 317-343.
39. McKerns K.W. (1969) Adrenocorticotrophin-induced generation of 5′-phosphoribosyl pyrophosphate and its relation to nucleotide synthesis in the adrenal cortex. Biochim. Biophys. Acta 192, 318-325.
40. McKerns K.W. & Ryschkewitsch W. (1963) ACTH stimulation of purine nucleotide synthesis in the adrenal cortex: ACTH stimulation of purine synthesis. Arch. Biochem. Biophys. 154, 341-347.
41. McKerns K.W. & Ryschkewitsch W. (1976) Regulation of RNA synthesis in corpora lutea nuclei by luteinizing hormone and derivatives. Biochim. Biophys. Acta 454, 51-54.
42. McLean P. (1959) Effect of insulin and phenazine methosulphate on pathways of glucose catabolism in the mammary gland of the rat. Nature 183, 182-183.
43. Mendley S. & Toback F.G. (1988) Autocrine and paracrine regulation of kidney epithelial cell growth. Annu. Rev. Physiol. 51, 33-50.
44. Menissier de Murcia J., Ricoul M., Tartier L. et al. (2003) Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J. 22, 2255-2263.
45. Michan S. & Sinclair D. (2007) Sirtuins in mammels: insights into their biological function. Biochem. J. 404, 1-13.
46. Morton R.K. (1958) Enzymic synthesis of coenzyme 1 in relation to chemical control of cell growth. Nature 181, 541-542.
47. Novello F. & McLean P. (1968) The pentose phosphate pathway of glucose metabolism. Measurement of the non-oxidative reactions of the cycle. Biochem. J. 107, 775-791.
48. Ørskov H., Flyvbjerg A., Frystyk J. et al. (1992) Octreotide and diabetes. Theoretical and experimental aspects. Metabolism 41(Suppl. 2), 66-71.
49. Penhoat A., Chatelain P.G., Jaillard C., Saez J.M. (1988) Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells: role of these peptides in adrenal cell function. Endocrinology 122, 2518-2526.
50. Rebuffat P., Belloni A.S., Malendowicz L.K., Mazzocchi G., Gottardo G., Nussdorfer G. (1988) Zona glomerulosa morphology and function in streptozotocin-induced diabetic rats. Endocrinology 123, 949-956.
51. Revollo J.R., Grimm A.A., Imai S. (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279, 50754-50763.
52. Revsin Y., van Wijk D., Saravia F.E., Oitzl M.S., De Nicola A.F., De Kloet E.R. (2008) Adrenal hypersensitivity precedes chronic hypercorticism in streptozotocin-induced diabetes mice. Endocrinology 149, 3531-3539.
53. Rhees C.W., Wilson C.T., Heninger R.W. (1983) Influence of streptozotocin diabetes and insulin therapy on plasma corticosterone in male rats. Horm. Metab. Res. 15, 353-354.
54. Rutter G.A. (2009) Regulating glucagons secretion: somatostatin in the spotlight. Diabetes 58, 299-301.
55. Sochor M., Gonzalez A.-M., McLean P. (1984) Regulation of glucose metabolism in rat adrenal gland in alloxan diabetes: possible role of fructose 2;6 bisphosphate. Biochem. Biophys. Res. Commun. 121, 8-13.
56. Sochor M., Baquer N.Z., McLean P. (1985) Glucose over- and under-utilization in diabetes: comparative studies on the changes in activities of enzymes of glucose metabolism in rat kidney and liver. Mol. Physiol. 7, 51-68.
57. Sochor M., Kunjara S., Greenbaum A.L., McLean P. (1989) Changes in pathways of pentose phosphate formation in relation to phosphoribosyl pyrophosphate synthesis in the developing rat kidney. Effects of glucose concentration and electron acceptors. J. Dev. Physiol. 12, 135-143.
58. Steer K.A., Sochor M., Kunjara S., Doepfner W., McLean P. (1988) The effect of a somatostatin analogue (SMS 201-995, Sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in early renal hypertrophy of experimental diabetes in the rat. Biochem. Med. Metab. Biol. 39, 226-233.
59. Taira M., Iizasa T., Yamada K., Shimada H., Tatibana M. (1989) Tissue-differential expression of two distinct genes for phosphoribosyl pyrophosphate synthetase and existence of the testis-specific transcript. Biochim. Biophys. Acta 1007, 203-208.
60. Tamakawa H., Miyata A., Satoh K. et al. (1998) The augmentation of pituitary adenylate cyclase activating polypeptide (PACAP) in streptozotocin- induced diabetic rats. Peptides 19, 1497-1502.
61. Tang-Fen T.L., Frank E., Ullrich A. (1985) Gene for human insulin receptor: localization to site on chromosome 19 involved in pre-B-cell leukaemia. Science 228, 728-731.
62. Vaudry D., Falluel-Morel A., Bourgault S. et al. (2009) Pituitary adenylate-cyclase activating polypeptide and its receptors: 20years after discovery. Pharmacol. Rev. 61, 283-357.
63. Von Werder K. & Foglia G. (1992) Potential indications for octreotide in endocrinology. Metabolism 41(Suppl. 2), 91-98.